156 related articles for article (PubMed ID: 35100440)
1. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study.
Hieken TJ; Sadurní MB; Quattrocchi E; Kobic A; Sominidi-Damodaran S; Dwarkasing JT; Meerstein-Kessel L; Bridges AG; Meves A
Int J Dermatol; 2022 Jul; 61(7):848-854. PubMed ID: 35100440
[TBL] [Abstract][Full Text] [Related]
2. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
[TBL] [Abstract][Full Text] [Related]
3. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis.
Thao V; Dholakia R; Moriarty JP; Borah BJ; Dwarkasing J; Meves A
Int J Dermatol; 2023 Jan; 62(1):56-61. PubMed ID: 36440797
[TBL] [Abstract][Full Text] [Related]
4. The incidence and cost implications of surgical site infection following lymph node surgery for skin malignancy.
McMillan AT; Ho NX; Izard C; Matteucci PL; Totty JP
J Plast Reconstr Aesthet Surg; 2023 Dec; 87():341-348. PubMed ID: 37925925
[TBL] [Abstract][Full Text] [Related]
5. Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2005 Sep; 31(7):778-83. PubMed ID: 15993029
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in patients with malignant melanoma: analysis of post-operative complications.
Solari N; Bertoglio S; Boscaneanu A; Minuto M; Reina S; Palombo D; Bruzzi P; Cafiero F
ANZ J Surg; 2019 Sep; 89(9):1041-1044. PubMed ID: 31368164
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy After Melanoma-A National Analysis of Recurrence Rates and Risk of Lymphedema.
Shen C; Shah JK; Cevallos P; Nazerali R; Rosen JM
Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S284-S292. PubMed ID: 38556691
[TBL] [Abstract][Full Text] [Related]
9. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature.
Moody JA; Botham SJ; Dahill KE; Wallace DL; Hardwicke JT
Eur J Surg Oncol; 2017 Sep; 43(9):1760-1767. PubMed ID: 28756017
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
11. Validation of CP-GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study.
Yousaf A; Tjien-Fooh FJ; Rentroia-Pacheco B; Quattrocchi E; Kobic A; Tempel D; Kolodney M; Meves A
Int J Dermatol; 2021 Jul; 60(7):851-856. PubMed ID: 33914348
[TBL] [Abstract][Full Text] [Related]
12. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
13. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
14. Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient's Perspective.
Banting S; Milne D; Thorpe T; Na L; Spillane J; Speakman D; Henderson MA; Gyorki DE
Ann Surg Oncol; 2019 Jul; 26(7):2263-2267. PubMed ID: 31011899
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
16. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
17. Morbidity of selective lymph node biopsy for melanoma: meta-analysis of complications.
Cigna E; Gradilone A; Ribuffo D; Gazzaniga P; Fino P; Sorvillo V; Scuderi N
Tumori; 2012; 98(1):94-8. PubMed ID: 22495708
[TBL] [Abstract][Full Text] [Related]
18. Consecutive Case Series of Melanoma Sentinel Node Biopsy for Lymphoseek Compared to Sulfur Colloids.
Silvestri C; Christopher A; Intenzo C; Kairys JC; Kim S; Willis A; Berger AC
J Surg Res; 2019 Jan; 233():149-153. PubMed ID: 30502241
[TBL] [Abstract][Full Text] [Related]
19. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
